Related Experiment Video
Updated: Jun 26, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Therapeutic challenges in the era of antibiotic resistance
1Infectious Disease Unit, Department of Medicine, Sungai Buloh Hospital, Jalan Hospital, Sungai Buloh, Selangor, Malaysia. chrislee@hkl.gov.my
Abstract:
Multidrug microbial resistance poses major challenges to the management of infection, particularly with the paucity of new drugs with activity against these bacteria. Since the turn of this century a few new antibiotics have been licensed, including linezolid, daptomycin and tigecycline. This supplement reports data presented at the 13th International Congress of Infectious Diseases held in Kuala Lumpur in June 2008. Dr R. Isturiz reviews the data on global resistance trends and the potential impact on empirical therapy; Dr J.-H. Song reviews new agents on the antimicrobial horizon; and the final paper in the supplement, by Dr L.R. Peterson, reviews the role of tigecycline in the management of complicated intra-abdominal and skin and soft tissue infections.
Related Concept Videos
Antibiotic Selection
Development of Antibiotic Resistance
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Microbiota Modulation by Antibiotics
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...